Enter inventor name

Ronald G Micetich

This inventor holds 42 USPTO granted patents, primarily in Cysteine Protease Inhibitors. Top assignees: Synphar Laboratories, Inc., Taiho Pharmaceutical Company Limited, Connlab Holdings Limited. Active years: 1977-2006.

USPTO Granted Patents = 42

% Patents Active = 90.5

Average Co-Inventor Count = 4.1

ph-index = 9

Forward Citations = 278(Granted Patents)

Location History:

Sherwoodk Park, CA (1993)
Edmonton, CA (1977 - 2003)
Alberta, CA (1985 - 2005)
Sherwood Park, CA (1979 - 2006)

Company Filing History:

15 out of 21

Synphar Laboratories, Inc.

patents

9 out of 320

Taiho Pharmaceutical Company Limited

patents

8 out of 9

Connlab Holdings Limited

patents

4. 4 out of 2,538

Warner-Lambert Company

patents

5. 2 out of 4

Naeja Pharmaceutical Inc.

patents

6. 2 out of 1,039

National Research Council of Canada

patents

7. 1 out of 1

Cdc Life Sciences Inc.

patent

8. 1 out of 1

Naeja Pharmaceuticals Inc.

Synphar Laboraties, Inc.

patent

11. 1 out of 1

Synphar Laboratories, Ind.

patent

12. 1 out of 1

Syphar Laboratories, Inc.

patent

where one patent can have more than one assignee

Years Active: 1977-2006

Loading Chart...

Areas of Expertise:

Cysteine Protease Inhibitors

Azetidinone Derivatives

Antibacterial Agents

Quinazolines

Isoquinolones

Beta-Lactamase Inhibitors

Penicillin Derivatives

Heterocycles

Thiazolines

Oligopeptides

Sulfonic Acids

3D-Structure Synthesis

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6982260 - Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes (2006-01-03),

2. 6916803 - 3-(Heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents (2005-07-12),

3. 6635621 - Cysteine protease inhibitors (2003-10-21),

4. 6569847 - Substituted azetidin-2-ones as cysteine protease inhibitors (2003-05-27),

5. 6362181 - Isoquinolones (2002-03-26),

6. 6232305 - Substituted amino bicyclic-&bgr;-lactam penam and cepham derivatives as cysteine protease inhibitors (2001-05-15),

7. 6177423 - Isoquinolones (2001-01-23),

8. 6133485 - Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl (2000-10-17),

9. 6057315 - Antibacterial agents (2000-05-02),

10. 6034077 - 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one (2000-03-07),

11. 5994340 - Azetidinone derivatives as .beta.-lactamase inhibitors (1999-11-30),

12. 5986108 - 4-substitued-3-[1 or 2 amino acid residue]-azetidin-2-one derivatives (1999-11-16),

13. 5959123 - 3,4-Disubstituted azetidin-2-one derivatives useful as cysteine (1999-09-28),

14. 5925633 - 3-Substituted-4-oxa-1-azabicyclo �3,2,0!heptan-7-one as cysteine (1999-07-20),

15. 5916887 - 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one (1999-06-29),

Title: Ronald G Micetich - Pioneering Inventor from Sherwood Park, CA

Introduction: Ronald G Micetich is a distinguished inventor hailing from Sherwood Park, CA, known for his groundbreaking contributions to the field of innovation.

Latest Patents: Ronald G Micetich holds several patents in various industries, showcasing his versatility and ingenuity in creating novel solutions to complex problems.

Career Highlights: Throughout his illustrious career, Ronald G Micetich has consistently pushed the boundaries of traditional thinking, leading to the development of cutting-edge technologies that have revolutionized the way we live and work.

Collaborations: Ronald G Micetich has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Ronald G Micetich's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, inspiring generations to come.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]